Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Manning

Showing results (681-690 of 729) with videos related to

Pageof 73
Sort By:
Journal for Immunotherapy of Cancer|June 15, 2025
Multiomics identifies tumor-intrinsic SREBP1 driving immune exclusion in hepatocellular carcinomaRebekah E Dadey, Ruxuan Li, Jake Griner, et al.
Neurology and Therapy|March 8, 2026
A Comparative Effectiveness Study of Lorazepam or IVIg Versus no Treatment for Down Syndrome Regression DisorderJonathan D Santoro, Saba Jafarpour, Panteha Hayati Rezvan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 19, 2008
Metabolism and disposition of dasatinib after oral administration to humansLisa J Christopher, Donghui Cui, Chiyuan Wu, et al.
Alcohol, Clinical & Experimental Research|December 17, 2023
Maternal risk factors for fetal alcohol spectrum disorders: Distal variablesPhilip A May, Julie M Hasken, Marlene M de Vries, et al.
Journal of Neurodevelopmental Disorders|June 6, 2022
Evidence of neuroinflammation and immunotherapy responsiveness in individuals with down syndrome regression disorderJonathan D Santoro, Rebecca Partridge, Runi Tanna, et al.
Drug and Alcohol Dependence|November 30, 2020
The prevalence, child characteristics, and maternal risk factors for the continuum of fetal alcohol spectrum disorders: A sixth population-based study in the same South African communityPhilip A May, Anna-Susan Marais, Marlene M De Vries, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|June 19, 2019
Glutamine Antagonist JHU083 Normalizes Aberrant Glutamate Production and Cognitive Deficits in the EcoHIV Murine Model of HIV-Associated Neurocognitive DisordersMichael T Nedelcovych, Boe-Hyun Kim, Xiaolei Zhu, et al.
Ultrasound Quarterly|June 6, 2014
National ultrasound curriculum for medical studentsOksana H Baltarowich, Donald N Di Salvo, Leslie M Scoutt, et al.
Drug and Alcohol Dependence|August 13, 2021
Estimating the community prevalence, child traits, and maternal risk factors of fetal alcohol spectrum disorders (FASD) from a random sample of school childrenPhilip A May, Julie M Hasken, Stephen R Hooper, et al.
Pediatrics|November 21, 2019
Early-Life Predictors of Fetal Alcohol Spectrum DisordersWendy O Kalberg, Philip A May, David Buckley, et al.
Pageof 73

Showing results (681-690 of 729) with videos related to

Sort By:
Pageof 73
Journal for Immunotherapy of Cancer|June 15, 2025
Multiomics identifies tumor-intrinsic SREBP1 driving immune exclusion in hepatocellular carcinomaRebekah E Dadey, Ruxuan Li, Jake Griner, et al.
Neurology and Therapy|March 8, 2026
A Comparative Effectiveness Study of Lorazepam or IVIg Versus no Treatment for Down Syndrome Regression DisorderJonathan D Santoro, Saba Jafarpour, Panteha Hayati Rezvan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 19, 2008
Metabolism and disposition of dasatinib after oral administration to humansLisa J Christopher, Donghui Cui, Chiyuan Wu, et al.
Alcohol, Clinical & Experimental Research|December 17, 2023
Maternal risk factors for fetal alcohol spectrum disorders: Distal variablesPhilip A May, Julie M Hasken, Marlene M de Vries, et al.
Journal of Neurodevelopmental Disorders|June 6, 2022
Evidence of neuroinflammation and immunotherapy responsiveness in individuals with down syndrome regression disorderJonathan D Santoro, Rebecca Partridge, Runi Tanna, et al.
Drug and Alcohol Dependence|November 30, 2020
The prevalence, child characteristics, and maternal risk factors for the continuum of fetal alcohol spectrum disorders: A sixth population-based study in the same South African communityPhilip A May, Anna-Susan Marais, Marlene M De Vries, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|June 19, 2019
Glutamine Antagonist JHU083 Normalizes Aberrant Glutamate Production and Cognitive Deficits in the EcoHIV Murine Model of HIV-Associated Neurocognitive DisordersMichael T Nedelcovych, Boe-Hyun Kim, Xiaolei Zhu, et al.
Ultrasound Quarterly|June 6, 2014
National ultrasound curriculum for medical studentsOksana H Baltarowich, Donald N Di Salvo, Leslie M Scoutt, et al.
Drug and Alcohol Dependence|August 13, 2021
Estimating the community prevalence, child traits, and maternal risk factors of fetal alcohol spectrum disorders (FASD) from a random sample of school childrenPhilip A May, Julie M Hasken, Stephen R Hooper, et al.
Pediatrics|November 21, 2019
Early-Life Predictors of Fetal Alcohol Spectrum DisordersWendy O Kalberg, Philip A May, David Buckley, et al.
Pageof 73